Pfizer
Search results
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.
Oct 26, 2023 · Bristol Myers Squibb posted third quarter revenues of $11.0 billion, a decrease of 2%, or 3% when adjusted for foreign exchange, due to lower sales of Revlimid, partially offset by our new product portfolio and in-line products.
Jun 18, 2024 · Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial
Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases.
Discover real-time Bristol-Myers Squibb Company Common Stock (BMY) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with...
Jun 24, 2024 · Bristol Myers Squibb added adagrasib via its $5 billion Mirati Therapeutics Inc. deal. The approval is based on results from cohorts of the Phase 1/2 KRYSTAL-1 open-label study, ...
Jun 5, 2024 · Who is Bristol-Myers Squibb. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide.
2 days ago · Bristol-Myers Squibb last announced its quarterly earnings results on April 25th, 2024. The biopharmaceutical company reported ($4.40) EPS for the quarter, topping the consensus estimate of ($4.53) by $0.13. The firm had revenue of $11.87 billion for the quarter, compared to analyst estimates of $11.45 billion.
View today's Bristol-Myers Squibb Company stock price and latest BMY news and analysis. Create real-time notifications to follow any changes in the live stock price.
